OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies
Wenhui Jia, Zhao Huang, Li Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100988-100988
Open Access | Times Cited: 13
Wenhui Jia, Zhao Huang, Li Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100988-100988
Open Access | Times Cited: 13
Showing 13 citing articles:
Cancer treatment therapies: traditional to modern approaches to combat cancers
Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9663-9676
Closed Access | Times Cited: 101
Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9663-9676
Closed Access | Times Cited: 101
Elucidating the Mechanisms of Acquired Palbociclib Resistance via Comprehensive Metabolomics Profiling
Lulu Yang, Yajun Yue, Zhendong Wang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 24-24
Open Access
Lulu Yang, Yajun Yue, Zhendong Wang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 24-24
Open Access
Metabolic Crosstalk between Platelets and Cancer: Mechanisms, Functions, and Therapeutic Potential
Zhixue Chen, Xu Lin, Yuan Yu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Zhixue Chen, Xu Lin, Yuan Yu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Zhong Chen, Guojuan Wang, Min Guo, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Zhong Chen, Guojuan Wang, Min Guo, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Construction of a Novel MitochondriaAssociated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival
Xiu Wang, Zhenhu Zhang, Yamin Shi, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 5, pp. 1164-1177
Open Access | Times Cited: 1
Xiu Wang, Zhenhu Zhang, Yamin Shi, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 5, pp. 1164-1177
Open Access | Times Cited: 1
Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition
Yicong Yao, Qinghua Wang, Wei Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37075-e37075
Open Access | Times Cited: 1
Yicong Yao, Qinghua Wang, Wei Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37075-e37075
Open Access | Times Cited: 1
Purines and purinergic receptors in primary tumors of the central nervous system
Adinei Abadio Soares, Helamã Moraes dos Santos, Keyllor Nunes Domann, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Adinei Abadio Soares, Helamã Moraes dos Santos, Keyllor Nunes Domann, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity
Jun Wu, Yu Rong, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jun Wu, Yu Rong, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers
XU Chang-fen, Peiyao Xu, Jiaqi Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
XU Chang-fen, Peiyao Xu, Jiaqi Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Editorial: ABC transporters and drug resistance
Qisi Lu, Suresh V. Ambudkar, Dong‐Hua Yang
Drug Resistance Updates (2024) Vol. 77, pp. 101135-101135
Closed Access
Qisi Lu, Suresh V. Ambudkar, Dong‐Hua Yang
Drug Resistance Updates (2024) Vol. 77, pp. 101135-101135
Closed Access
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Exploring Shared Targets in Cancer Immunotherapy and Cancer-Induced Bone Pain: Insights from Preclinical Studies
Ruofan Zhang, Yachen Yang, Xiang Li, et al.
Cancer Letters (2024) Vol. 611, pp. 217399-217399
Closed Access
Ruofan Zhang, Yachen Yang, Xiang Li, et al.
Cancer Letters (2024) Vol. 611, pp. 217399-217399
Closed Access
